Skip to main content
Clinical Trials/NCT06935695
NCT06935695RecruitingNot Applicable

Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)

Icahn School of Medicine at Mount Sinai1 site in 1 country50 target enrollmentStarted: January 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
50
Locations
1
Primary Endpoint
Number of stent-related complications warranting an intervention

Study Overview

Brief Summary

Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting.

Exclusion Criteria

  • •Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment.
  • •Lobar or segmental stents alone
  • •Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy
  • •Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks)
  • •Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)

Arms & Interventions

Surveillance Group

Experimental

Patients will be scheduled to undergo a surveillance bronchoscopy 4-6 weeks after the stent insertion.

Intervention: Bronchoscopy (Device)

No Surveillance

Active Comparator

Patients will only undergo bronchoscopies if warranted by clinical symptoms deemed to be secondary to stent-related complications.

Intervention: Bronchoscopy (Device)

Outcomes

Primary Outcomes

Number of stent-related complications warranting an intervention

Time Frame: 3 months after enrollment

Possible complications: Stent migration, biofilm formation, obstructive mucus plugging, obstructive granulation requiring intervention

Secondary Outcomes

  • Protocol Feasibility Composite Score(3 months after enrollment)
  • Number of unscheduled visits due to stent-related complications(3 months after enrollment)
  • Number of hospitalizations due to stent-related complications(3 months after enrollment)
  • Number of urgent care or emergency room visits due to stent-related complications(3 months after enrollment)
  • Number of stent-related complications as detected during a bronchoscopy or on cross-sectional imaging(3 months after enrollment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Udit Chaddha

Associate Professor of Medicine

Icahn School of Medicine at Mount Sinai

Study Sites (1)

Loading locations...

Similar Trials

Surveillance Versus Bronchoscopy After... | Clinical Trial